Discover recent investing articles from Finimize about

#stocks

Stéphane Renevier, CFA

european central bank

Paul Allison, CFA

Stéphane Renevier, CFA

federal reserve

Paul Allison, CFA

interest rates

Stéphane Renevier, CFA

Reda Farran, CFA

Theodora Lee Joseph, CFA

Stéphane Renevier, CFA

european central bank

Paul Allison, CFA

Stéphane Renevier, CFA

federal reserve

Paul Allison, CFA

interest rates

Stéphane Renevier, CFA

Reda Farran, CFA

Theodora Lee Joseph, CFA

Stéphane Renevier, CFA

european central bank

Paul Allison, CFA

Stéphane Renevier, CFA

federal reserve

Paul Allison, CFA

interest rates

Stéphane Renevier, CFA

Reda Farran, CFA

Theodora Lee Joseph, CFA

Explore more topics

central banks

#stocks

Your Daily Brief For September 30th

Nike’s better-than-expected results drew a loud cheer from investors, while eurozone inflation took a steeper fall than anticipated

Eurozone Inflation Dipped By More Than Expected

Eurozone inflation took a steeper fall than anticipated, hitting its lowest point in two years

Nike’s Results Have Everybody Hooping For The Best

Nike’s better-than-expected results drew a loud cheer from investors, or at least a ripple of applause

Four Lessons We Can Learn From The Last 100 Inflation Bouts

History might not always repeat itself, but it sure does often. So let’s look back at the last fifty years of inflation spikes to see what could be ahead of us this time around.

One Company Measurement You Need To Check When Interest Rates Are High

Higher borrowing costs have brought the way a CEO splashes shareholders’ cash into sharper focus, and this handy metric can tell you everything you need to know.

Your Daily Brief For September 29th

A key benchmark of US oil prices hit its highest point in over a year, while global deal activity sunk to a decade low

Looks Like Global Deal Activity Has Fizzled Out

Global deal activity sunk to a decade low, indicating that high interest rates are slowing down both businesses and banks

The Biggest Winners And Losers Of The Weight-Loss Drug Theme

Weight-loss drugs are suddenly in vogue, and their ability to tackle obesity and related ailments will whip a few companies into good shape – and leave others losing out.

BlackRock’s Dumping ESG Funds. Here’s Whether You Should Do The Same.

ESG funds are dividing investors and politicians alike. Let’s find out why, and whether the furore is justified.

Your Daily Brief For September 28th

OpenAI announced a potential share sale that could triple its valuation from earlier this year, while organized crime took aim at Target, forcing it to shutter nine US stores

Your Daily Brief For September 30th

Nike’s better-than-expected results drew a loud cheer from investors, while eurozone inflation took a steeper fall than anticipated

Eurozone Inflation Dipped By More Than Expected

Eurozone inflation took a steeper fall than anticipated, hitting its lowest point in two years

Nike’s Results Have Everybody Hooping For The Best

Nike’s better-than-expected results drew a loud cheer from investors, or at least a ripple of applause

Four Lessons We Can Learn From The Last 100 Inflation Bouts

History might not always repeat itself, but it sure does often. So let’s look back at the last fifty years of inflation spikes to see what could be ahead of us this time around.

One Company Measurement You Need To Check When Interest Rates Are High

Higher borrowing costs have brought the way a CEO splashes shareholders’ cash into sharper focus, and this handy metric can tell you everything you need to know.

Your Daily Brief For September 29th

A key benchmark of US oil prices hit its highest point in over a year, while global deal activity sunk to a decade low

Looks Like Global Deal Activity Has Fizzled Out

Global deal activity sunk to a decade low, indicating that high interest rates are slowing down both businesses and banks

The Biggest Winners And Losers Of The Weight-Loss Drug Theme

Weight-loss drugs are suddenly in vogue, and their ability to tackle obesity and related ailments will whip a few companies into good shape – and leave others losing out.

BlackRock’s Dumping ESG Funds. Here’s Whether You Should Do The Same.

ESG funds are dividing investors and politicians alike. Let’s find out why, and whether the furore is justified.

Your Daily Brief For September 28th

OpenAI announced a potential share sale that could triple its valuation from earlier this year, while organized crime took aim at Target, forcing it to shutter nine US stores

Your Daily Brief For September 30th

Nike’s better-than-expected results drew a loud cheer from investors, while eurozone inflation took a steeper fall than anticipated

Eurozone Inflation Dipped By More Than Expected

Eurozone inflation took a steeper fall than anticipated, hitting its lowest point in two years

Nike’s Results Have Everybody Hooping For The Best

Nike’s better-than-expected results drew a loud cheer from investors, or at least a ripple of applause

Four Lessons We Can Learn From The Last 100 Inflation Bouts

History might not always repeat itself, but it sure does often. So let’s look back at the last fifty years of inflation spikes to see what could be ahead of us this time around.

One Company Measurement You Need To Check When Interest Rates Are High

Higher borrowing costs have brought the way a CEO splashes shareholders’ cash into sharper focus, and this handy metric can tell you everything you need to know.

Your Daily Brief For September 29th

A key benchmark of US oil prices hit its highest point in over a year, while global deal activity sunk to a decade low

Looks Like Global Deal Activity Has Fizzled Out

Global deal activity sunk to a decade low, indicating that high interest rates are slowing down both businesses and banks

The Biggest Winners And Losers Of The Weight-Loss Drug Theme

Weight-loss drugs are suddenly in vogue, and their ability to tackle obesity and related ailments will whip a few companies into good shape – and leave others losing out.

BlackRock’s Dumping ESG Funds. Here’s Whether You Should Do The Same.

ESG funds are dividing investors and politicians alike. Let’s find out why, and whether the furore is justified.

Your Daily Brief For September 28th

OpenAI announced a potential share sale that could triple its valuation from earlier this year, while organized crime took aim at Target, forcing it to shutter nine US stores